Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Eton Pharmaceuticals, Inc is a biotechnology business based in the US. Eton Pharmaceuticals shares (ETON) are listed on the NASDAQ and all prices are listed in US Dollars. Eton Pharmaceuticals employs 17 staff and has a trailing 12-month revenue of around USD$417,000.
|Latest market close||USD$8.66|
|52-week range||USD$2.5 - USD$9.12|
|50-day moving average||USD$7.9567|
|200-day moving average||USD$7.0685|
|Wall St. target price||USD$16.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-3.071|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-15)||-4.52%|
|1 month (2020-12-23)||-0.12%|
|3 months (2020-10-22)||9.07%|
|6 months (2020-07-22)||48.03%|
|1 year (2020-01-22)||25.69%|
|2 years (2019-01-22)||41.97%|
|3 years (2018-01-19)||N/A|
|5 years (2016-01-19)||N/A|
|Gross profit TTM||USD$506,000|
|Return on assets TTM||-112.18%|
|Return on equity TTM||-334.58%|
|Market capitalisation||USD$212.6 million|
TTM: trailing 12 months
There are currently 851,569 Eton Pharmaceuticals shares held short by investors – that's known as Eton Pharmaceuticals's "short interest". This figure is 18% down from 1.0 million last month.
There are a few different ways that this level of interest in shorting Eton Pharmaceuticals shares can be evaluated.
Eton Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Eton Pharmaceuticals shares currently shorted divided by the average quantity of Eton Pharmaceuticals shares traded daily (recently around 199898.82629108). Eton Pharmaceuticals's SIR currently stands at 4.26. In other words for every 100,000 Eton Pharmaceuticals shares traded daily on the market, roughly 4260 shares are currently held short.
However Eton Pharmaceuticals's short interest can also be evaluated against the total number of Eton Pharmaceuticals shares, or, against the total number of tradable Eton Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eton Pharmaceuticals's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Eton Pharmaceuticals shares in existence, roughly 40 shares are currently held short) or 0.0563% of the tradable shares (for every 100,000 tradable Eton Pharmaceuticals shares, roughly 56 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eton Pharmaceuticals.
Find out more about how you can short Eton Pharmaceuticals stock.
We're not expecting Eton Pharmaceuticals to pay a dividend over the next 12 months.
Over the last 12 months, Eton Pharmaceuticals's shares have ranged in value from as little as $2.5 up to $9.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eton Pharmaceuticals's is 1.2887. This would suggest that Eton Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.